Amicus Therapeutics Inc (FOLD) — Tangible Net Worth Ratio
Amicus Therapeutics Inc (FOLD) has a Tangible Net Worth Ratio of 94.9% as of December 2025. This metric is calculated by deducting intangible assets ($13.91 Million) from net assets ($274.24 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Amicus Therapeutics Inc (FOLD) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Amicus Therapeutics Inc Tangible Net Worth Ratio (2004–2025)
This chart shows how Amicus Therapeutics Inc's Tangible Net Worth Ratio has changed across 20 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 94.9%, reflecting net assets of $274.24 Million with intangible assets of $13.91 Million USD. For live market cap and overall valuation, see Amicus Therapeutics Inc stock valuation.
Annual Tangible Net Worth Ratio for Amicus Therapeutics Inc (2004–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Amicus Therapeutics Inc from 2004 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of Amicus Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | $274.24 Million | $13.91 Million | $949.87 Million | ▲ +3.8 pp |
| 2024 | 91.1% | $194.04 Million | $17.20 Million | $785.03 Million | ▲ +3.9 pp |
| 2023 | 87.2% | $160.17 Million | $20.49 Million | $777.88 Million | ▲ +5.9 pp |
| 2022 | 81.3% | $123.05 Million | $23.00 Million | $724.17 Million | ▼ -11.2 pp |
| 2021 | 92.5% | $307.37 Million | $23.00 Million | $905.14 Million | ▲ +0.5 pp |
| 2020 | 92.0% | $286.38 Million | $23.00 Million | $886.52 Million | ▼ -3.2 pp |
| 2019 | 95.2% | $476.43 Million | $23.00 Million | $850.21 Million | ▲ +1.9 pp |
| 2018 | 93.3% | $342.91 Million | $23.00 Million | $789.95 Million | ▼ -0.2 pp |
| 2017 | 93.5% | $352.85 Million | $23.00 Million | $627.02 Million | ▲ +128.6 pp |
| 2016 | -35.1% | $360.15 Million | $486.70 Million | $1.04 Billion | ▲ +4.8 pp |
| 2015 | -39.9% | $347.83 Million | $486.70 Million | $908.38 Million | ▼ -121.1 pp |
| 2014 | 81.2% | $122.18 Million | $23.00 Million | $209.97 Million | ▲ +31.4 pp |
| 2013 | 49.7% | $45.75 Million | $23.00 Million | $127.56 Million | ▼ -50.3 pp |
| 2012 | 100.0% | $69.22 Million | $0.00 | $110.09 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $29.59 Million | $0.00 | $69.80 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $64.93 Million | $0.00 | $112.55 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $71.83 Million | $0.00 | $85.37 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $71.04 Million | $0.00 | $128.77 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $103.30 Million | $0.00 | $167.10 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $4.15 Million | $0.00 | $5.07 Million | — |